Abstract
Percutaneous thermal ablation therapies have been receiving increasing attention as potential primary treatments for focal HCC and liver metastases. Possible advantages of ablative therapies as compared to surgical resection include a lower morbidity and mortality rate, lower costs, the suitability for real time imaging guidance, the option to perform ablative procedures on outpatients, and the potential application to a wider spectrum of patients, including those who are unsuitable as surgical candidates. Therefore, the major advantage of RFA is its ability to create a well-controlled focal thermal injury in the liver resulting in high success rates in treating HCC nodules and metastases smaller than 3 cm in diameter with long-term outcome results comparable to surgery. Besides the accepted application of thermal ablation in patients suffering from liver tumors, RFA has a rapidly growing role in tumors beyond the liver. Especially in renal and lung cancer, RF ablation shows very promising results; however, larger studies are still missing proving its effectiveness regarding the long-term follow-up.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allaf ME, Varkarakis IM, Bhayani SB et al. (2005) Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation—initial observations. Radiology 237:366–370
Bilchik AJ, Wood TF, Allegra DP (2001) Radiofrequency ablation of unresectable hepatic malignancies: lessons learned. Oncologist 6: 24–33
Buscarini L, Buscarini E (2001) Therapy of HCC radiofrequency ablation. Hepatogastroenterology 48:15–19
Buscarini L, Buscarini E, Di Stasi M et al. (2001) Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11:914–921
Curley SA, Izzo F, Delrio P et al. (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230:1–8
Curley SA, Izzo F, Ellis LM et al. (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232:381–391
Curley SA (2003) Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 10:338–347
Curley SA, Marra P, Beaty K et al. (2004) Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239:450–458
de Baere T, Elias D, Dromain C et al. (2000) Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 175:1619–1625
Gillams AR, Lees WR (2004) Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261–2267
Goetz MP, Callstrom MR, Charboneau JW et al. (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22:300–306
Goldberg SN and Gazelle GS (2001) Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology 48:359–367
Haber GP, Gill IS (2006) Laparoscopic partial nephrectomy: contemporary technique and outcomes. Eur Urol 49:660–665
Hacker A, Vallo S, Weiss C et al. (2005) Minimally invasive treatment of renal cell carcinoma: comparison of four different monopolar radiofrequency devices. Eur Urol 48:584–592
Helmberger T, Dogan S, Straub G et al. (2007) Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. Digestion 75:104–112
Hoffmann RT, Jakobs TF, Lubienski A et al. (2006) Percutaneous radiofrequency ablation of pulmonary tumors—is there a difference between treatment under general anaesthesia and under conscious sedation? Eur J Radiol 59:168–174
Johnson DB, Solomon SB, Su LM et al. (2004) Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol 172:874–877
Kelekis AD, Thanos L, Mylona S et al. (2006) Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: current status. Eur Radiol 16:2471–2482
Lencioni R, Cioni D, Crocetti L et al. (2005a) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967
Lencioni R, Della Pina C, Bartolozzi C (2005b) Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom Imaging 30:401–408
Liu LX, Jiang HC, Piao DX (2002) Radiofrequence ablation of liver cancers. World J Gastroenterol 8:393–399
Livraghi T, Meloni F (2001) Removal of liver tumours using radiofrequency waves. Ann Chir Gynaecol 90:239–245
Livraghi T, Solbiati L, Meloni MF et al. (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–451
Lotan Y, Cadeddu JA (2005) A cost comparison of nephron-sparing surgical techniques for renal tumour. BJU Int 95:1039–1042
McGahan JP, Browning PD, Brock JM et al. (1990) Hepatic ablation using radiofrequency electrocautery. Invest Radiol 25:267–270
McGahan JP, Gu WZ, Brock JM et al. (1996) Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol 3:418–422
Mouraviev V, Joniau S, Van Poppel H et al. (2007) Current status of minimally invasive ablative techniques in the treatment of small renal tumours. Eur Urol 51:328–336
Mulier S, Mulier P, Ni Y et al. (2002) Complications of radiofrequency coagulation of liver tumours. Br J Surg 89:1206–1222
Ohlsson B, Stenram U, Tranberg KG (1998) Resection of colorectal liver metastases: 25-year experience. World J Surg 22:268–276; discussion 276–267
Pereira PL, Trubenbach J, Schmidt D (2003) [Radiofrequency ablation: basic principles, techniques and challenges]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 175:20–27
Poon RT, Fan ST, Tsang FH et al. (2002) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 235:466–486
Scheele J, Stang R, Altendorf-Hofmann A et al. (1995) Resection of colorectal liver metastases. World J Surg 19:59–71
Solbiati L, Ierace T, Tonolini M et al. (2001) Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 13:149–158
Tateishi R, Shiina S, Teratani T et al. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1,000 cases. Cancer 103:1201–1209
Tranberg KG (2004) Percutaneous ablation of liver tumours. Best Pract Res Clin Gastroenterol 18:125–145
Uzzo RG, Novick AC (2001) Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 166:6–18
Woertler K, Vestring T, Boettner F et al. (2001) Osteoid osteoma: CT-guided percutaneous radiofrequency ablation and follow-up in 47 patients. J Vasc Interv Radiol 12:717–722
Wood TF, Rose DM, Chung M et al. (2000) Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7:593–600
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hoffmann, RT., Jakobs, T., Trumm, C., Reiser, M. (2009). CT-Guided Tumor Ablation. In: Reiser, M., Becker, C., Nikolaou, K., Glazer, G. (eds) Multislice CT. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33125-4_39
Download citation
DOI: https://doi.org/10.1007/978-3-540-33125-4_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33124-7
Online ISBN: 978-3-540-33125-4
eBook Packages: MedicineMedicine (R0)